On January 28th, the "Bonjour No. 1 Hyaluronic Acid for Injection New Product Launch" was successfully held at Shanghai Bund No. 3. "Bonjour No. 1" is an international high-end medical aesthetic redream Weilin Group that has been innovating and developing for many years, integrating the concept of oriental aesthetics with patented biotechnology and comfortable plastic beauty experience, and is committed to creating excellent products with both safety and oriental aesthetics for consumers with innovative technology in the new era of medical aesthetic development.
Industry leaders and guests cut the ribbon for the listing of "Bonjour No. 1".
On the same day, Yan Dongfang, President of Shanghai Association of Medical Institutions, Wu Xiaojun, President of the Injury Treatment Branch of China Plastic Surgery Association, Liu Haijuan, General Manager of Sales of East Region of Medical Aesthetic Division of Bloomage Biopharmaceutical and Medical Device Line, Liao Yong, Medical General Manager of Medical Aesthetic Division of Bloomage Biopharmaceutical and Medical Device Line, Zhan Zongyang, President of REDREAM Weilin Group, general managers of many Weilin Medical Aesthetic Hospitals across the country and experts in the field of beauty gathered together to witness the brilliant opening of "Bonjour No. 1".
President Wu Xiaojun delivered a speech on the spot.
At the press conference, Wu Xiaojun, President of the Injury Treatment Branch of China Plastic Surgery Association, brought a keynote speech on "The Importance of Products for Injection Effect and Safety" from the professional perspective of hyaluronic acid injection, especially pointing out that medical beauty should return to the essence of medicine, take safety as the bottom line, and at the same time should focus on aesthetic presentation and effect for the purpose of bringing consumers high-quality products with both safety and aesthetics. Bonjour No. 1 hyaluronic acid for injection relies on the international R&D team and rich clinical experience of REDREAM Weilin Group, and adopts the triple core technology of Bloomage Biotech - HEC30-3D high-efficiency gradient cross-linking, BioBT20 isotonic and lidocaine 24H sustained-release to create a technical benchmark, the most hardcore of which is Bloomage Biotech HEC3The 0-3D high-efficiency gradient cross-linking technology locks the HA molecules layer by layer to form an interpenetrating lock self-winding to reduce the addition of cross-linking agents but still obtain the effect of high-efficiency cross-linking, while the lidocaine embedding and sustained-release technology can achieve pain relief for up to 24 hours and reduce the pain of consumers in the process of seeking beauty.
Bloomage Biopharmaceutical Device Line Medical Aesthetic Division made a technical introduction.
Subsequently, Yan Dongfang, vice president of the China Association of Non-public Medical Institutions and president of the Shanghai Association of Social Medical Institutions, made a guiding speech from the macro perspective of the market and the industry, emphasizing that the medical industry should always adhere to the "production line is the safety line". For a long time, as a high-end medical aesthetic brand, REDREAM Weilin has always been committed to promoting the high-quality development of the industry. As a medical aesthetic technology product that has been researched and developed for many years, Weilin Group has always insisted on continuously focusing on supervision and reform from product research and development to technical polishing to clinical testing, fully ensuring the safety and effectiveness of products, and building a high-quality safety production line for consumers from all aspects.
Product display at the press conference.
In addition to striving for excellence in product research and development and process standards, the R&D team of "Bonjour No. 1" is rooted in oriental aesthetics, closely follows the cutting-edge trends of the consumer market, and starts from the massive clinical cases of Weilin Medical Aesthetics for many years to effectively create injectable hyaluronic acid products that meet the oriental aesthetics. On the day of the press conference, Bonjour No. 1 has received praise and recommendations from many doctors by virtue of strict raw material quality control standards, advanced penetration technology, WYSIWYG product effects, and on-site inspection standards of the quality management system of China, the United States and South Korea.